top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
Autore Ecke Thorsten
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (240 p.)
Soggetto topico Medicine
Soggetto non controllato Metallothionein
urothelium
urothelial cancer
cadmium exposure
zinc transporter
bladder
TAGLN
F-actin
PTEN
p53
tumorigenesis
proliferation
invasion
TERT promoter mutations
FGFR3
non muscle invasive bladder cancer
BCG therapy
bladder cancer
JAK-STAT pathway
combination therapy
oncolytic adenovirus
virotherapy
STAT3/5 inhibitor
JAK inhibitor
XVir-N-31
bladder cancer detection
urinary biomarkers
DNA methylation
ECRG4
ITIH5
biomarker
cancer
grade
metabolomics
MS
NMR
biomarkers
tumor markers
prognosis
heparanase
syndecan-1
heparan sulfate proteoglycans (HSPGs)
urothelial carcinoma
miRNA
quantitative PCR
tumor marker
voided urine cytology
KDM7A
histone demethylase
TC-E 5002
androgen receptor
drug resistance
non-invasive detection
telomerase
somatic mutations
TERT promoter region
muscle-invasive bladder cancer
chemotherapy
immunotherapy
personalized medicine
predictive biomarker
survivin
BIRC5
macrophage
KRT20
ERBB2
MIBC
prediction
RT-qPCR
adjuvant chemotherapy
survival
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557142003321
Ecke Thorsten  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Integrating Clinical and Translational Research Networks-Building Team Medicine
Integrating Clinical and Translational Research Networks-Building Team Medicine
Autore Salgia Ravi
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (250 p.)
Soggetto topico Medicine
Soggetto non controllato renal cell carcinoma
team medicine
translational research
community practice
clinical trials
geriatric oncology
older adults
cancer clinical trials
recruitment
community
team science
bladder cancer
urothelial carcinoma
COVID-19
team-based medicine
colorectal cancer
precisian medicine
academic and community oncology
cancer center
lung cancer
lung cancer screening
low-dose CT scans
cancer prevention
smoking cessation
tobacco control
national guidelines for screening and prevention
pharmaceutical aids to smoking cessation
non-small cell lung cancer
driver mutations
testing rates
receptor tyrosine kinases
actionable mutations
next-generation sequencing
fast-and-frugal trees
personalized medicine
minorities
ethnicity
race
breast cancer
research
HER2-directed therapy
community oncology
academic cancer center
precision medicine
cancer genetics
cancer genomics
small cell lung cancer
immunotherapy
epithelial ovarian cancer
frontline treatment
surgical debulking
adjuvant chemotherapy
maintenance therapy
PARP inhibitor
genetics counseling
clinical research
oropharyngeal cancer
concurrent chemoradiation therapy
human papillomavirus
feeding tube dependency
value-based care
value-based cancer care
oncology pathways
Early Recovery After Surgery (ERAS)
team-based care
oncology medical home
integrated cancer care
supportive care pathways
surgical pathways
cancer care plans
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557124403321
Salgia Ravi  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Outcomes and Therapeutic Management of Bladder Cancer
Outcomes and Therapeutic Management of Bladder Cancer
Autore Moschini Marco
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (120 p.)
Soggetto topico Medicine
Soggetto non controllato bladder cancer
robotic-assisted
open
radical cystectomy
survival
propensity score
age
urothelial carcinoma
outcome
anesthesia recovery periods
cognitive impairment
gamma-cyclodextrins
neuromuscular blockade
robotic radical cystectomy
glycogen
clear-cell adenocarcinoma
urinary bladder
SEER program database
female
intracorporeal neobladder
outcomes
robotic
sex-sparing
methylation
biomarkers
FOXA1
GATA3
KRT20
molecular markers
mRNA
muscle-invasive bladder cancer
PCR
human epidermal growth factor receptor 2
indoleamine 2,3-dioxygenase
programmed death ligand-1
immunotherapy
nodal disease
pN1
neoadjuvant
adjuvant
chemotherapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557114503321
Moschini Marco  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Role of Medical Imaging in Cancers . Volume 1
Role of Medical Imaging in Cancers . Volume 1
Autore Fanti Stefano
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (312 pages)
Soggetto topico Medicine
Soggetto non controllato positron emission tomography
head and neck neoplasms
neovascularization
pathologic
PET/CT
urothelial carcinoma
bladder cancer
upper tract urothelial carcinoma
survival
PET
PSMA
prostate
DCFPyL
DCFBC
PSMA-1007
ovarian cancer
relapse
SUVmax
targeted therapy
prognosis
soft tissue sarcoma (STS)
pazopanib
dynamic 18F-FDG PET/CT
SUV
two-tissue compartment model
magnetic resonance imaging
machine learning
diffusion
perfusion
texture analysis
squamous cell carcinoma of the head and neck
diffusion-weighted imaging
malignant pleural mesothelioma
pleural dissemination
empyema
pleural effusion
mCRPC
SPECT/CT
Computer-assisted diagnosis
XOFIGO
Therapy response assessment
circulating miRNAs
breast cancer
imaging parameters
PET/MRI
biomarkers
triple negative breast cancer
VCAM-1
SPECT imaging
sdAbs
Hounsfield unit
computed tomography
adipose tissue
precision oncology
FDG-PET/CT
PERCIST
metastatic breast cancer
prostate cancer
18F-FACBC
recurrence
meta-analysis
review
meningioma
somatostatin receptor
neuroimaging
radionuclide therapy
breast
imaging
marker
radiomics
Yin Yang 1
PDAC
Mesothelin
noninvasive imaging
receptor status
molecular imaging
nuclear medicine
guidelines
overutilization
epistemology
consensus
mantle cell lymphoma
18F-FDG PET/CT
Deauville criteria
Radium-223
FDG
castrate resistant prostate cancer
programmed cell death 1 receptor
diagnostic imaging
CTLA-4 Antigen
Immunotherapy
Adoptive
radioactive tracers
radionuclide imaging
CD8-Positive T-Lymphocytes
PI-RADS
diffusion kurtosis imaging
dynamic contrast-enhanced magnetic resonance imaging
68Gallium-PSMA PET/CT
prostate-specific-antigen
PSA kinetics thresholds
biochemical recurrence
optimal cutoff level
non-small-cell lung cancer
circulating tumor cells
immunotherapy
response to treatment
head and neck cancer
HPV
EBV
p16
Molecular imaging
miRNA expression
radiogenomics
radiomic
diagnosis
biomarker
glioblastoma
radiation therapy
MRI
diffusion tensor imaging
Hodgkin lymphoma
diffuse large B-cell lymphoma
staging
response assessment
locally advanced cervical cancer
concurrent chemoradiotherapy
treatment response
follow up
cystic tumor
International Consensus Guidelines
intraductal papillary mucinous neoplasms
pancreatic neoplasms
PD-1
PD-L1
response to therapy
NSCLC
positron-emission tomography
single-photon emission computed tomography
immune checkpoint inhibitors
gold nanoparticle
heat shock protein 70
spectral-CT
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557432103321
Fanti Stefano  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Role of Medical Imaging in Cancers . Volume 2
Role of Medical Imaging in Cancers . Volume 2
Autore Fanti Stefano
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (228 p.)
Soggetto topico Medicine
Soggetto non controllato positron emission tomography
head and neck neoplasms
neovascularization
pathologic
PET/CT
urothelial carcinoma
bladder cancer
upper tract urothelial carcinoma
survival
PET
PSMA
prostate
DCFPyL
DCFBC
PSMA-1007
ovarian cancer
relapse
SUVmax
targeted therapy
prognosis
soft tissue sarcoma (STS)
pazopanib
dynamic 18F-FDG PET/CT
SUV
two-tissue compartment model
magnetic resonance imaging
machine learning
diffusion
perfusion
texture analysis
squamous cell carcinoma of the head and neck
diffusion-weighted imaging
malignant pleural mesothelioma
pleural dissemination
empyema
pleural effusion
mCRPC
SPECT/CT
Computer-assisted diagnosis
XOFIGO
Therapy response assessment
circulating miRNAs
breast cancer
imaging parameters
PET/MRI
biomarkers
triple negative breast cancer
VCAM-1
SPECT imaging
sdAbs
Hounsfield unit
computed tomography
adipose tissue
precision oncology
FDG-PET/CT
PERCIST
metastatic breast cancer
prostate cancer
18F-FACBC
recurrence
meta-analysis
review
meningioma
somatostatin receptor
neuroimaging
radionuclide therapy
breast
imaging
marker
radiomics
Yin Yang 1
PDAC
Mesothelin
noninvasive imaging
receptor status
molecular imaging
nuclear medicine
guidelines
overutilization
epistemology
consensus
mantle cell lymphoma
18F-FDG PET/CT
Deauville criteria
Radium-223
FDG
castrate resistant prostate cancer
programmed cell death 1 receptor
diagnostic imaging
CTLA-4 Antigen
Immunotherapy
Adoptive
radioactive tracers
radionuclide imaging
CD8-Positive T-Lymphocytes
PI-RADS
diffusion kurtosis imaging
dynamic contrast-enhanced magnetic resonance imaging
68Gallium-PSMA PET/CT
prostate-specific-antigen
PSA kinetics thresholds
biochemical recurrence
optimal cutoff level
non-small-cell lung cancer
circulating tumor cells
immunotherapy
response to treatment
head and neck cancer
HPV
EBV
p16
Molecular imaging
miRNA expression
radiogenomics
radiomic
diagnosis
biomarker
glioblastoma
radiation therapy
MRI
diffusion tensor imaging
Hodgkin lymphoma
diffuse large B-cell lymphoma
staging
response assessment
locally advanced cervical cancer
concurrent chemoradiotherapy
treatment response
follow up
cystic tumor
International Consensus Guidelines
intraductal papillary mucinous neoplasms
pancreatic neoplasms
PD-1
PD-L1
response to therapy
NSCLC
positron-emission tomography
single-photon emission computed tomography
immune checkpoint inhibitors
gold nanoparticle
heat shock protein 70
spectral-CT
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557309503321
Fanti Stefano  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Urological Cancer 2020
Urological Cancer 2020
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (334 pages)
Soggetto topico Research
Biology
Soggetto non controllato renal cell carcinoma
iron
macrophages
chelation therapy
urothelial carcinoma
transcriptome
microtubule
MAP1B
prognosis
KLF5
androgen receptor
cell proliferation
tumorigenesis
prostate cancer
precision medicine
whole genome sequencing
optical mapping
therapy
prostate carcinoma
prostate mpMRI
machine learning
artificial intelligence
deep learning
neural network
angiogenesis
angiogenic growth factors
antiangiogenic therapy
renal tumors
prevention
α1-adrenoceptor antagonists
anoikis
vascularity
research model
oncogenes
tumor suppressor genes
MR-guided
radiotherapy
MRgRT
stereotactic ablative radiotherapy
stereotactic ablative radiation therapy (SABR)
renal cell cancer
RCC
online adaptive
[68Ga]Ga-PSMA PET/CT
dual-time point imaging
delayed imaging
biphasic imaging
lesion positivity rate
CXCL9
PD1
PD-L1
stage T1 NMIBC
prostatic neoplasms/mortality
prostatic neoplasms/epidemiology
SEER Program
bladder cancer
transurethral resection
en-bloc resection
CPT1A
fatty acids
serine
androgen response
ROS
oxidative stress
DONSON
Downstream Neighbor of SON
biomarker
metastatic spread
diagnosis
differential diagnosis
histopathology
immunohistochemistry
stroma signature
patient-derived xenografts
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557354903321
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Urological Cancer 2021
Urological Cancer 2021
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (328 pages)
Soggetto topico Research
Chemistry
Soggetto non controllato bladder cancer
radiotherapy
radiosensitisation
molecular subtypes
preclinical studies
bladder cancer cell lines
latent cancer
prostate cancer
autopsy
prognostic index
prediction model
mortality
screening trial
renal cell carcinoma
PD-1
PD-L1
biomarkers
immune checkpoint inhibitors
prostatic neoplasms
positron-emission tomography
decision making
tumor thrombus
metastasectomy
postoperative complications
oncological outcomes
radical cystectomy
AHNAK2
prognosis
dog
comparative oncology
inflammation
prostatic atrophy
preneoplastic lesion
biomarker
urine
machine learning
TRIPOD
liquid biopsy
glutaminase
immunohistochemistry
in situ methods
prostate
PSMA-RLT
177Lu-PSMA
PSA
mCRPC
urinary bladder neoplasms
Bacillus Calmette-Guérin (BCG)
immunotherapy
divergent differentiation
variant morphology
survival
stereotactic body radiotherapy
frail patients
cancer
metastasis
genomic analysis
microenvironment
tumor ecology
game theory
fluorescence confocal microscopy
prostate biopsy
ablation margins
focal therapy
sphingosine 1-phosphate receptor 1
bladder carcinoma
cell migration
epithelial-mesenchymal transition
FTY-720
OIP5
papillary renal cell carcinoma
PLK1
tumorigenesis
therapy
image-guided
magnetic resonance imaging
ultrasonography
biopsy
abiraterone
enzalutamide
docetaxel
novel hormonal therapies
comparative effectiveness
real-world treatment pattern
metastatic prostate cancer
epiplakin
diagnosis
advanced urothelial carcinoma
immune checkpoint inhibitor
prognostic
tumour mutational board
genomic signatures
ctDNA
inflammatory indices
urothelial carcinoma
frailty
prognostic factor
psoas muscle
Hounsfield units
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576872803321
MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui